FDA Import Refusal SCS-3200504-6/11/1 — Vyas Pharmaceuticals
The FDA refused shipment SCS-3200504-6/11/1 from Vyas Pharmaceuticals (India) on August 31, 2022. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- August 31, 2022
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66VBY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,75